1 The Global Coalition on Women and AIDS. World Health Organization. http://www.unaids.org.

2 Centers for Disease Control. HIV/AIDS Surveillance Report, 2004 (Vol 16). Atlanta: US Department of health and Human Services, CDC; 2005: 1–46. http://www.cdc.gov/hiv/topics.

3 Centers for Disease Control. HIV/AIDS Surveillance Report, 2003 (Vol 15). Atlanta: US Department of health and Human Services, CDC; 2005: 1–46. http://www.cdc.gov/hiv/topics/

4 Turmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet. 2003 Sep;82(3):411–8.

5 Lavreys L, Baeten JM, Martin HL Jr, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS. 2004 Mar 5;18(4):695–7.

6 Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005 Oct 1;366(9492):1182–8.

7 Anastos K, Gange SJ, Lau B, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):218–26.

8 Cohen MH, Cook JA, Grey D, Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004 Jul;94(7):1147–51.

9 Schooley RT. Starting highly active antiretroviral therapy for HIV infection: is it WIHS to wait? Ann Intern Med. 2004 Feb 17;140(4):305–6.

10 Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44:499–523.

11 Madan RP, Keller MJ, Herold BC. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides. Curr Opin Infect Dis. 2006 Feb;19(1):49–54. Review.

12 Vaccines. NIH fiscal year 2007 plan for HIV-related research. Available at: http://www.nih.gov/od.

13 Office of AIDS Research, National Institutes of Health, US Dept of Health and Human Services. FY2005 budget. http://www.nih.gov/od.

14 Lindegren ML, Byers RH Jr, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999 Aug 11;282(6):531–8.

15 Massad LS, Springer G, Jacobson L, et al. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS. 2004 Jan 23;18(2):281–6.

16 US Department of Health and Human Services. Office of the Inspector General. Reducing Obstetrician barriers to offivering HIV testing. Apr 2002. Available at: http://oig.hhs.gov/oei/

17 Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIVpositive veterans. J Gen Intern Med. 2005 Dec;20(12):1142–5.

18 Siegel K, Karus D, Dean L. Psychosocial Characteristics of New York City HIV-lnfected Women: Before and After the Advent of HAART. American Journal of Public Health. 2004; 94(7): 1127.

19 Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004 Jul;94(7):1133–40.

20 Gardner LI, Holmberg SD, Moore J, Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):69–75.

21 Shah M, Tierney K, Adams-Huet B, et al. The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy. HIV Med. 2005 Jul;6(4):291–8.

22 Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005 Jun 10; 308(5728):1582-3. Review.

.....

© 2006 NWHRC. All rights reserved. Reproduction of material published in the National Women's Health Report is encouraged with written permission from NWHRC. Write to NWHRC, 157 Broad Street, Suite 315, Red Bank, NJ 07701, call 1-877-986-9472 (toll-free) or email info@healthywomen.org.

Disclaimer